| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |